Identifying Products for Drug Development Programs
15 Mar 2014

This white paper describes how the 505(b)(2) services offered by Camargo, can help pharmaceutical companies to identify and assist in the development of its 505(b)(2) candidate.

Show    per page
1 of 1     Page  1 Next 
CMC for 505(b)(2) Applications pharmaceuticals10 Mar 2014Read
Understanding the 505(b)(2) Approval Pathway pharmaceuticals10 Mar 2014Read
ImmunoSIGNAL™ Cytokine Storm monoclonal antibodies, cytotoxicity, therapeutic antibodies10 Dec 2013Read
Development of an In Vitro Pre-clinical Cellular Assay to Predict monoclonal antibodies, cytotoxicity, cardiotoxicity9 Dec 2013Read
KRAS Mutation Detection by Compact Sequencing Compared with Real-Time Detection PCR and Pyrosequencing in the Routine Clinical Laboratory colorectal cancer, companion diagnostics15 Nov 2013Read
Gold and Silver Coated Nano Particles: Characterizing Coating Thickness for Nano-scale Drug Delivery drug delivery, particle sizing, particle size analysis29 Jul 2013Read
Adenovirus Particles: Monitoring the Production and Purification Process particle sizing, particle size analysis, gene therapy29 Jul 2013Read
Good Westerns Gone Bad: Tips to Make Your NIR Western Blot Great25 Jul 2013Read
Extended Immunological Analysis of Two Phase 1 Clinical Trials of MVA-BN®-HER2 in HER-2 overexpressing Metastatic Breast Cancer Patients cancer, peptides, HER228 Jun 2013Read

Popular tags in SelectScience

Buying guides

Write a Review

Join the Global SelectScience Community Today! It’s FREE!

Helping you make informed decisions about the latest lab products and technologies:

  • Be the first to learn about new technologies
  • 10,000+ trusted product reviews from your peers
  • Compare 500,000 products and manufacturers
  • Get exclusive buying tips from experts
  • Find solutions fast: 10,000+ Application Notes, Webinars and Videos

Connect with 250,000 scientists... All in one place!

Become a member today!